Lorenz, Katrin <br/><br/>
A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol for a randomised controlled trial.  [electronic resource] 

 -  Trials  03 2017 
 - 128 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1745-6215 
<br/><br/><label>Standard No.: </label>10.1186/s13063-017-1861-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Ophthalmic<br/>Angiogenesis Inhibitors--administration & dosage<br/>Clinical Protocols<br/>Double-Blind Method<br/>Europe<br/>Glaucoma, Neovascular--etiology<br/>Gonioscopy<br/>Humans<br/>Insulin Receptor Substrate Proteins--genetics<br/>Intraocular Pressure--drug effects<br/>Neovascularization, Pathologic<br/>Oligonucleotides--administration & dosage<br/>Ophthalmic Solutions<br/>Prospective Studies<br/>Research Design<br/>Retinal Neovascularization--etiology<br/>Retinal Vein Occlusion--complications<br/>Signal Transduction--drug effects<br/>Time Factors<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--metabolism<br/>Vascular Endothelial Growth Factor A--metabolism